The Project
Smart 4 Fabry

SMART-4-FABRYIN A BRIEF

Smart-4-Fabry has been conceived and created to obtain a new nanoformulation of GLA, that will improve the efficacy and toleration compared to the actual treatment with non-formulated GLA. The final benefit will be seen as considerable reduction on the Fabry disease treatment cost and a substantial improvement in the life-quality of Fabry disease patients.

Smart-4-Fabry will impact on a major health problem, the existence of new therapies for rare diseases, which constitutes a priority societal challenge as shown in the H2020 Work Programmes.

Title

Smart functional GLA-nanoformulation for Fabry disease”

Call

H2020-NMBP-2016-2017

Topic

NMBP-10-2016

Funding scheme

RIA

Acronym

Smart-4-Fabry

EC Contribution

5.844.508€

Duration

48 months

Starting date

1rst January 2017

Grant Agreement

720942

GENERALINFORMATION

Objectives

Achieve | Provide | Develop | Create

Read

BACKGROUND

About Fabry Disease

Read

PROJECT STRUCTURE

Work plan for Smart-4-Fabry

Read